1. Granot N, Storb R. History of hematopoietic cell transplantation: challenges and progress. Haematologica 2020;105:2716–2729.

2. Kean LS, Blazar BR. Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation. J Clin Invest 2024;134:e179944.

3. Zeiser R, Blazar BR. Acute graft-versus-host disease - biologic process, prevention, and therapy. N Engl J Med 2017;377:2167–2179.

4. Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Current concepts and advances in graft-versus-host disease immunology. Annu Rev Immunol 2021;39:19–49.

5. Zeiser R. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol 2019;187:563–572.

6. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity 2013;38:414–423.

7. Dikiy S, Rudensky AY. Principles of regulatory T cell function. Immunity 2023;56:240–255.

8. Sakaguchi S. Taking regulatory T cells into medicine. J Exp Med 2021;218:e20210831.

9. Morina L, Jones ME, Oguz C, et al. Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease. Front Immunol 2023;14:1114780.

10. Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 2011;131:1853–1860.

11. Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med 2011;17:673–675.

12. Wang T, Sun X, Zhao J, et al. Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood. Ann Rheum Dis 2015;74:1293–1301.

13. Choi YS, Jung MK, Lee J, et al. Tumor necrosis factor-producing T-regulatory cells are associated with severe liver injury in patients with acute hepatitis A. Gastroenterology 2018;154:1047–1060.

14. Lee JM, Kim DY, Cho HJ, et al. Reduced-intensity chemotherapy with tyrosine kinase inhibitor followed by allogeneic transplantation is effective in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Korean J Intern Med 2025;40:124–134.

15. Hong KT, Kim BK, An HY, et al. Comparing haploidentical transplantation with post-transplantation cyclophosphamide and umbilical cord blood transplantation using targeted busulfan in children and adolescents with hematologic malignancies. Blood Res 2025;60:7.

16. Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant 2016;22:4–10.

17. Rodríguez-Gil A, Pérez-Simón JA, Ritz J, Lacerda JF, Soares MV. Editorial: regulatory T cells in graft versus host disease. Front Immunol 2023;13:1085220.

18. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009;30:899–911.

19. Choi YS, Lee J, Lee HW, et al. Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. Gut 2015;64:1303–1313.

20. Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 2019;50:302–316.

21. Miyao T, Floess S, Setoguchi R, et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012;36:262–275.

22. Saini C, Sapra L, Bhardwaj A, et al. IL-21 plays an important role in modulating “Th17-Treg” cell axis in leprosy Type 1 reactions. Cytokine 2022;152:155821.

23. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010;40:1830–1835.

24. Bidgoli A, DePriest BP, Saatloo MV, Jiang H, Fu D, Paczesny S. Current definitions and clinical implications of biomarkers in graft-versus-host disease. Transplant Cell Ther 2022;28:657–666.

25. Skartsis N, Peng Y, Ferreira LMR, et al. IL-6 and TNFα drive extensive proliferation of human Tregs without compromising their lineage stability or function. Front Immunol 2021;12:783282.

26. Tavaf MJ, Verkiani ME, Hanzaii FP, Zomorrod MS. Effects of immune system cells in GvHD and corresponding therapeutic strategies. Blood Res 2023;58:2–12.